Kaplan–Meier survival curves further revealed the positive correlation between MAGT1 expression and the poor prognosis of patients with glioma in TCGA-GBM and TCGA-LGG cohorts (Figure 1)). This evidence concerns the gene MAGT1 and glioblastoma.